chr16-88643461-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_000101.4(CYBA):c.480G>A(p.Pro160=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0243 in 1,530,872 control chromosomes in the GnomAD database, including 549 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.022 ( 44 hom., cov: 33)
Exomes 𝑓: 0.025 ( 505 hom. )
Consequence
CYBA
NM_000101.4 synonymous
NM_000101.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -6.79
Genes affected
CYBA (HGNC:2577): (cytochrome b-245 alpha chain) Cytochrome b is comprised of a light chain (alpha) and a heavy chain (beta). This gene encodes the light, alpha subunit which has been proposed as a primary component of the microbicidal oxidase system of phagocytes. Mutations in this gene are associated with autosomal recessive chronic granulomatous disease (CGD), that is characterized by the failure of activated phagocytes to generate superoxide, which is important for the microbicidal activity of these cells. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.66).
BP6
Variant 16-88643461-C-T is Benign according to our data. Variant chr16-88643461-C-T is described in ClinVar as [Benign]. Clinvar id is 284654.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-88643461-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-6.8 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.0216 (3293/152114) while in subpopulation AMR AF= 0.0314 (481/15300). AF 95% confidence interval is 0.0291. There are 44 homozygotes in gnomad4. There are 1617 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 44 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYBA | NM_000101.4 | c.480G>A | p.Pro160= | synonymous_variant | 6/6 | ENST00000261623.8 | NP_000092.2 | |
CYBA | XM_011522905.4 | c.*1705G>A | 3_prime_UTR_variant | 6/6 | XP_011521207.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYBA | ENST00000261623.8 | c.480G>A | p.Pro160= | synonymous_variant | 6/6 | 1 | NM_000101.4 | ENSP00000261623 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0217 AC: 3296AN: 152006Hom.: 44 Cov.: 33
GnomAD3 genomes
AF:
AC:
3296
AN:
152006
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0231 AC: 2951AN: 127656Hom.: 56 AF XY: 0.0224 AC XY: 1568AN XY: 70082
GnomAD3 exomes
AF:
AC:
2951
AN:
127656
Hom.:
AF XY:
AC XY:
1568
AN XY:
70082
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0246 AC: 33882AN: 1378758Hom.: 505 Cov.: 37 AF XY: 0.0243 AC XY: 16518AN XY: 680362
GnomAD4 exome
AF:
AC:
33882
AN:
1378758
Hom.:
Cov.:
37
AF XY:
AC XY:
16518
AN XY:
680362
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0216 AC: 3293AN: 152114Hom.: 44 Cov.: 33 AF XY: 0.0217 AC XY: 1617AN XY: 74360
GnomAD4 genome
AF:
AC:
3293
AN:
152114
Hom.:
Cov.:
33
AF XY:
AC XY:
1617
AN XY:
74360
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
27
AN:
3448
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 03, 2015 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative Benign:2
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 01, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Nov 19, 2015 | - - |
Chronic granulomatous disease Benign:1
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at